Andisheh Eslamboli
Affiliations: | University of Cambridge, Cambridge, England, United Kingdom |
Google:
"Andisheh Eslamboli"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Eslamboli A, Romero-Ramos M, Burger C, et al. (2007) Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain : a Journal of Neurology. 130: 799-815 |
| Eslamboli A, Grundy RI, Irving EA. (2006) Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys. Neuroscience Letters. 408: 89-93 |
| Eslamboli A. (2005) Assessment of GDNF in primate models of Parkinson's disease: comparison with human studies. Reviews in the Neurosciences. 16: 303-10 |
| Eslamboli A. (2005) Marmoset monkey models of Parkinson's disease: which model, when and why? Brain Research Bulletin. 68: 140-9 |
| Eslamboli A, Georgievska B, Ridley RM, et al. (2005) Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 769-77 |
| Eslamboli A, Cummings RM, Ridley RM, et al. (2003) Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus). Experimental Neurology. 184: 536-48 |
| Eslamboli A, Baker HF, Ridley RM, et al. (2003) Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys. Experimental Neurology. 183: 418-29 |